Delivery Order SPE2DB22D3011-SPE2DB25FQ1FF
Award Date
6/11/25
Potential Completion Date
7/3/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INBRIJA 42 MG INHALATION CAP 60S. The contract has a ceiling value of $1,294.24 and runs through April 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The order is for the provision of INBRIJA 42 MG INHALATION CAP 60S, a specialty pharmaceutical product, with a ceiling value of $1,251.00 and a period of performance through April 19, 2024. AmerisourceBergen Drug Corp also holds an indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a $1,251.00 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564542915 INBRIJA 42 MG INHALATION CAP 60S. The contract has an ultimate completion date of May 30, 2024. This order is placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,294.24 firm-fixed-price delivery order is for the supply of INBRIJA 42 MG INHALATION CAP 60S, a prescription medication. The contract has a performance period through June 5, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of the pharmaceutical product INBRIJA 42 MG INHALATION CAP 60S, with a ceiling value of $1,251.00 and a period of performance through April 2, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp, a for-profit organization, is the...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product. The award has a total ceiling value of $7,506.00 and a period of performance through May 3, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product, with a potential value of $1,876.50. This contract has a completion date of March 13, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as a prime contractor to DLA Troop Support Medical, providing a range of pharmaceutical products and...
This federal contract award, valued at $1,294.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INBRIJA 42 MG INHALATION CAP 60S, a medical product, with an ultimate completion date of April 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $1,294.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product, with a completion date of February 12, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The firm fixed price delivery order, valued at $1,251.00, is for the supply of the pharmaceutical product INBRIJA 42 MG INHALATION CAP 60S. This award does not have a set-aside designation. The delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA,...